Related references
Note: Only part of the references are listed.Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
RESPIRATORY MORBIDITY IN ADULTHOOD AFTER RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATION IN INFANCY
Marja Ruotsalainen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial
Xavier Carbonell-Estrany et al.
PEDIATRICS (2010)
Respiratory Morbidity and Lung Function in Preterm Infants of 32 to 36 Weeks' Gestational Age
Andrew A. Colin et al.
PEDIATRICS (2010)
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
Nele Sigurs et al.
THORAX (2010)
Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life
Michael L. Forbes et al.
JOURNAL OF MEDICAL ECONOMICS (2010)
Challenges in developing a pediatric RSV vaccine
Jeanne H. Schickli et al.
HUMAN VACCINES (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes
Bernhard Resch et al.
PAEDIATRIC RESPIRATORY REVIEWS (2009)
The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
Rachel Ochola et al.
PLOS ONE (2009)
Policy Statement-Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
Joseph A. Bocchini et al.
PEDIATRICS (2009)
Pulmonary Eosinophilia Is Attenuated by Early Responding CD8+ Memory T Cells in a Murine Model of RSV Vaccine-Enhanced Disease
Whitney W. Stevens et al.
VIRAL IMMUNOLOGY (2009)
A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life
Marie-Louise von Linstow et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Overcoming T-cell-mediated immunopathology to achieve safe respiratory syncytial virus vaccination
Elaine M. Castilow et al.
FUTURE VIROLOGY (2008)
Respiratory syncytial virus (RSV) vaccines - Two steps back for one leap forward
Ultan F. Power
JOURNAL OF CLINICAL VIROLOGY (2008)
Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan
Kecia N. Carroll et al.
PEDIATRICS (2008)
Viral and host factors in human respiratory syncytial virus pathogenesis
Peter L. Collins et al.
JOURNAL OF VIROLOGY (2008)
Late-preterm infants: A population at risk
William A. Engle et al.
PEDIATRICS (2007)
Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course
Anja Wilkesmann et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Immunopathology of RSV infection: prospects for developing vaccines without this complication
S. van Drunen Littel-van den Hurk et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age
B Resch et al.
JOURNAL OF INFECTION (2005)
Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain
J Figueras-Aloy et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
The progression of maternal RSV antibodies in the offspring
M Hacimustafaoglu et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV
TR Johnson et al.
JOURNAL OF VIROLOGY (2004)
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines
AP Durbin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P
LM Haynes et al.
JOURNAL OF VIROLOGY (2003)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
FM Munoz et al.
VACCINE (2003)
Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection
RC Welliver
JOURNAL OF PEDIATRICS (2003)
Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia
DF Willson et al.
JOURNAL OF PEDIATRICS (2003)
Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease
EAF Simoes
JOURNAL OF PEDIATRICS (2003)
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
S Leader et al.
JOURNAL OF PEDIATRICS (2003)
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999
S Leader et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity
M Lanari et al.
PEDIATRIC PULMONOLOGY (2002)
Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults
UF Power et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
GA Prince et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine
EM Ponnuraj et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons
X Carbonell-Estrany et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
TG Boyce et al.
JOURNAL OF PEDIATRICS (2000)
Share Paper
